 | • レポートコード：GIR-23F0320 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Anti-infective API Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の抗感染原薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 抗感染原薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・β-ラクタム系薬剤、マクロライド系薬剤、カルバペネム系薬剤、キノロン系薬剤 アプリケーション別セグメントは次のように区分されます。 ・全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗マイコバクテリア薬、ワクチン、その他 世界の抗感染原薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・North China Pharmaceutical、CSPC、Harbin Pharmaceutical Group Pharmaceutical General Factory、Henan Huaxing Pharmaceutical Factory、Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical、Zhangjiakou Diha Pharmaceutical、Shandong Lukang Medicine、Zhuhai United Laboratories、Lunan Pharmaceutical Group、Sandoz 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 抗感染原薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：β-ラクタム系薬剤、マクロライド系薬剤、カルバペネム系薬剤、キノロン系薬剤 - アプリケーション別分析（2017年vs2021年vs2028年）：全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗マイコバクテリア薬、ワクチン、その他 - 世界の抗感染原薬市場規模・予測 - 世界の抗感染原薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - North China Pharmaceutical、CSPC、Harbin Pharmaceutical Group Pharmaceutical General Factory、Henan Huaxing Pharmaceutical Factory、Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical、Zhangjiakou Diha Pharmaceutical、Shandong Lukang Medicine、Zhuhai United Laboratories、Lunan Pharmaceutical Group、Sandoz ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：β-ラクタム系薬剤、マクロライド系薬剤、カルバペネム系薬剤、キノロン系薬剤 ・アプリケーション別分析2017年-2028年：全身用抗菌薬、全身用抗ウイルス薬、全身用抗原、細菌、免疫血清・免疫グロブリン、抗マイコバクテリア薬、ワクチン、その他 ・抗感染原薬の北米市場分析 - 抗感染原薬の北米市場：タイプ別市場規模2017年-2028年 - 抗感染原薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・抗感染原薬のヨーロッパ市場分析 - ：抗感染原薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：抗感染原薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・抗感染原薬のアジア太平洋市場分析 - 抗感染原薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 抗感染原薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・抗感染原薬の南米市場分析 - 抗感染原薬の南米市場：タイプ別市場規模2017年-2028年 - 抗感染原薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・抗感染原薬の中東・アフリカ市場分析 - 抗感染原薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 抗感染原薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti-infective API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti-infective API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Antibacterial Drugs for Systemic Use accounting for % of the Anti-infective API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While β-lactam Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti-infective API include North China Pharmaceutical, CSPC, Harbin Pharmaceutical Group Pharmaceutical General Factory, Henan Huaxing Pharmaceutical Factory, and Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti-infective API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
β-lactam Drugs
Macrolides
Carbapenems
Quinolones
Market segment by Application can be divided into
Antibacterial Drugs for Systemic Use
Antiviral Drugs for Systemic Use
Antigen for Whole Body
Bacteria
Immune Serum and Immunoglobulin
Anti-mycobacterial Drugs
Vaccine
Other
The key market players for global Anti-infective API market are listed below:
North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-infective API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-infective API, with price, sales, revenue and global market share of Anti-infective API from 2019 to 2022.
Chapter 3, the Anti-infective API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-infective API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti-infective API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-infective API.
Chapter 13, 14, and 15, to describe Anti-infective API sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Anti-infective API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-infective API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 β-lactam Drugs
1.2.3 Macrolides
1.2.4 Carbapenems
1.2.5 Quinolones
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-infective API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Antibacterial Drugs for Systemic Use
1.3.3 Antiviral Drugs for Systemic Use
1.3.4 Antigen for Whole Body
1.3.5 Bacteria
1.3.6 Immune Serum and Immunoglobulin
1.3.7 Anti-mycobacterial Drugs
1.3.8 Vaccine
1.3.9 Other
1.4 Global Anti-infective API Market Size & Forecast
1.4.1 Global Anti-infective API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti-infective API Sales in Volume (2017-2028)
1.4.3 Global Anti-infective API Price (2017-2028)
1.5 Global Anti-infective API Production Capacity Analysis
1.5.1 Global Anti-infective API Total Production Capacity (2017-2028)
1.5.2 Global Anti-infective API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-infective API Market Drivers
1.6.2 Anti-infective API Market Restraints
1.6.3 Anti-infective API Trends Analysis
2 Manufacturers Profiles
2.1 North China Pharmaceutical
2.1.1 North China Pharmaceutical Details
2.1.2 North China Pharmaceutical Major Business
2.1.3 North China Pharmaceutical Anti-infective API Product and Services
2.1.4 North China Pharmaceutical Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSPC
2.2.1 CSPC Details
2.2.2 CSPC Major Business
2.2.3 CSPC Anti-infective API Product and Services
2.2.4 CSPC Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Harbin Pharmaceutical Group Pharmaceutical General Factory
2.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Details
2.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Major Business
2.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product and Services
2.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Henan Huaxing Pharmaceutical Factory
2.4.1 Henan Huaxing Pharmaceutical Factory Details
2.4.2 Henan Huaxing Pharmaceutical Factory Major Business
2.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Product and Services
2.4.4 Henan Huaxing Pharmaceutical Factory Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
2.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Details
2.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Major Business
2.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product and Services
2.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Zhangjiakou Diha Pharmaceutical
2.6.1 Zhangjiakou Diha Pharmaceutical Details
2.6.2 Zhangjiakou Diha Pharmaceutical Major Business
2.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Product and Services
2.6.4 Zhangjiakou Diha Pharmaceutical Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shandong Lukang Medicine
2.7.1 Shandong Lukang Medicine Details
2.7.2 Shandong Lukang Medicine Major Business
2.7.3 Shandong Lukang Medicine Anti-infective API Product and Services
2.7.4 Shandong Lukang Medicine Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zhuhai United Laboratories
2.8.1 Zhuhai United Laboratories Details
2.8.2 Zhuhai United Laboratories Major Business
2.8.3 Zhuhai United Laboratories Anti-infective API Product and Services
2.8.4 Zhuhai United Laboratories Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Lunan Pharmaceutical Group
2.9.1 Lunan Pharmaceutical Group Details
2.9.2 Lunan Pharmaceutical Group Major Business
2.9.3 Lunan Pharmaceutical Group Anti-infective API Product and Services
2.9.4 Lunan Pharmaceutical Group Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Sandoz
2.10.1 Sandoz Details
2.10.2 Sandoz Major Business
2.10.3 Sandoz Anti-infective API Product and Services
2.10.4 Sandoz Anti-infective API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti-infective API Breakdown Data by Manufacturer
3.1 Global Anti-infective API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti-infective API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti-infective API
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-infective API Manufacturer Market Share in 2021
3.4.2 Top 6 Anti-infective API Manufacturer Market Share in 2021
3.5 Global Anti-infective API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti-infective API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-infective API Market Size by Region
4.1.1 Global Anti-infective API Sales in Volume by Region (2017-2028)
4.1.2 Global Anti-infective API Revenue by Region (2017-2028)
4.2 North America Anti-infective API Revenue (2017-2028)
4.3 Europe Anti-infective API Revenue (2017-2028)
4.4 Asia-Pacific Anti-infective API Revenue (2017-2028)
4.5 South America Anti-infective API Revenue (2017-2028)
4.6 Middle East and Africa Anti-infective API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti-infective API Sales in Volume by Type (2017-2028)
5.2 Global Anti-infective API Revenue by Type (2017-2028)
5.3 Global Anti-infective API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti-infective API Sales in Volume by Application (2017-2028)
6.2 Global Anti-infective API Revenue by Application (2017-2028)
6.3 Global Anti-infective API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti-infective API Sales by Type (2017-2028)
7.2 North America Anti-infective API Sales by Application (2017-2028)
7.3 North America Anti-infective API Market Size by Country
7.3.1 North America Anti-infective API Sales in Volume by Country (2017-2028)
7.3.2 North America Anti-infective API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-infective API Sales by Type (2017-2028)
8.2 Europe Anti-infective API Sales by Application (2017-2028)
8.3 Europe Anti-infective API Market Size by Country
8.3.1 Europe Anti-infective API Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti-infective API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti-infective API Sales by Type (2017-2028)
9.2 Asia-Pacific Anti-infective API Sales by Application (2017-2028)
9.3 Asia-Pacific Anti-infective API Market Size by Region
9.3.1 Asia-Pacific Anti-infective API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti-infective API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti-infective API Sales by Type (2017-2028)
10.2 South America Anti-infective API Sales by Application (2017-2028)
10.3 South America Anti-infective API Market Size by Country
10.3.1 South America Anti-infective API Sales in Volume by Country (2017-2028)
10.3.2 South America Anti-infective API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-infective API Sales by Type (2017-2028)
11.2 Middle East & Africa Anti-infective API Sales by Application (2017-2028)
11.3 Middle East & Africa Anti-infective API Market Size by Country
11.3.1 Middle East & Africa Anti-infective API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti-infective API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti-infective API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti-infective API
12.3 Anti-infective API Production Process
12.4 Anti-infective API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti-infective API Typical Distributors
13.3 Anti-infective API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Anti-infective API Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti-infective API Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. North China Pharmaceutical Major Business
Table 5. North China Pharmaceutical Anti-infective API Product and Services
Table 6. North China Pharmaceutical Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CSPC Basic Information, Manufacturing Base and Competitors
Table 8. CSPC Major Business
Table 9. CSPC Anti-infective API Product and Services
Table 10. CSPC Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Harbin Pharmaceutical Group Pharmaceutical General Factory Basic Information, Manufacturing Base and Competitors
Table 12. Harbin Pharmaceutical Group Pharmaceutical General Factory Major Business
Table 13. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product and Services
Table 14. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Henan Huaxing Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 16. Henan Huaxing Pharmaceutical Factory Major Business
Table 17. Henan Huaxing Pharmaceutical Factory Anti-infective API Product and Services
Table 18. Henan Huaxing Pharmaceutical Factory Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Major Business
Table 21. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product and Services
Table 22. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Zhangjiakou Diha Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Zhangjiakou Diha Pharmaceutical Major Business
Table 25. Zhangjiakou Diha Pharmaceutical Anti-infective API Product and Services
Table 26. Zhangjiakou Diha Pharmaceutical Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shandong Lukang Medicine Basic Information, Manufacturing Base and Competitors
Table 28. Shandong Lukang Medicine Major Business
Table 29. Shandong Lukang Medicine Anti-infective API Product and Services
Table 30. Shandong Lukang Medicine Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Zhuhai United Laboratories Major Business
Table 33. Zhuhai United Laboratories Anti-infective API Product and Services
Table 34. Zhuhai United Laboratories Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Lunan Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 36. Lunan Pharmaceutical Group Major Business
Table 37. Lunan Pharmaceutical Group Anti-infective API Product and Services
Table 38. Lunan Pharmaceutical Group Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Sandoz Basic Information, Manufacturing Base and Competitors
Table 40. Sandoz Major Business
Table 41. Sandoz Anti-infective API Product and Services
Table 42. Sandoz Anti-infective API Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Anti-infective API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 44. Global Anti-infective API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Anti-infective API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Anti-infective API Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 47. Head Office and Anti-infective API Production Site of Key Manufacturer
Table 48. Anti-infective API New Entrant and Capacity Expansion Plans
Table 49. Anti-infective API Mergers & Acquisitions in the Past Five Years
Table 50. Global Anti-infective API Sales by Region (2017-2022) & (Kiloton)
Table 51. Global Anti-infective API Sales by Region (2023-2028) & (Kiloton)
Table 52. Global Anti-infective API Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Anti-infective API Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Anti-infective API Sales by Type (2017-2022) & (Kiloton)
Table 55. Global Anti-infective API Sales by Type (2023-2028) & (Kiloton)
Table 56. Global Anti-infective API Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Anti-infective API Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Anti-infective API Price by Type (2017-2022) & (US$/Ton)
Table 59. Global Anti-infective API Price by Type (2023-2028) & (US$/Ton)
Table 60. Global Anti-infective API Sales by Application (2017-2022) & (Kiloton)
Table 61. Global Anti-infective API Sales by Application (2023-2028) & (Kiloton)
Table 62. Global Anti-infective API Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Anti-infective API Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Anti-infective API Price by Application (2017-2022) & (US$/Ton)
Table 65. Global Anti-infective API Price by Application (2023-2028) & (US$/Ton)
Table 66. North America Anti-infective API Sales by Country (2017-2022) & (Kiloton)
Table 67. North America Anti-infective API Sales by Country (2023-2028) & (Kiloton)
Table 68. North America Anti-infective API Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Anti-infective API Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Anti-infective API Sales by Type (2017-2022) & (Kiloton)
Table 71. North America Anti-infective API Sales by Type (2023-2028) & (Kiloton)
Table 72. North America Anti-infective API Sales by Application (2017-2022) & (Kiloton)
Table 73. North America Anti-infective API Sales by Application (2023-2028) & (Kiloton)
Table 74. Europe Anti-infective API Sales by Country (2017-2022) & (Kiloton)
Table 75. Europe Anti-infective API Sales by Country (2023-2028) & (Kiloton)
Table 76. Europe Anti-infective API Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Anti-infective API Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Anti-infective API Sales by Type (2017-2022) & (Kiloton)
Table 79. Europe Anti-infective API Sales by Type (2023-2028) & (Kiloton)
Table 80. Europe Anti-infective API Sales by Application (2017-2022) & (Kiloton)
Table 81. Europe Anti-infective API Sales by Application (2023-2028) & (Kiloton)
Table 82. Asia-Pacific Anti-infective API Sales by Region (2017-2022) & (Kiloton)
Table 83. Asia-Pacific Anti-infective API Sales by Region (2023-2028) & (Kiloton)
Table 84. Asia-Pacific Anti-infective API Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Anti-infective API Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Anti-infective API Sales by Type (2017-2022) & (Kiloton)
Table 87. Asia-Pacific Anti-infective API Sales by Type (2023-2028) & (Kiloton)
Table 88. Asia-Pacific Anti-infective API Sales by Application (2017-2022) & (Kiloton)
Table 89. Asia-Pacific Anti-infective API Sales by Application (2023-2028) & (Kiloton)
Table 90. South America Anti-infective API Sales by Country (2017-2022) & (Kiloton)
Table 91. South America Anti-infective API Sales by Country (2023-2028) & (Kiloton)
Table 92. South America Anti-infective API Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Anti-infective API Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Anti-infective API Sales by Type (2017-2022) & (Kiloton)
Table 95. South America Anti-infective API Sales by Type (2023-2028) & (Kiloton)
Table 96. South America Anti-infective API Sales by Application (2017-2022) & (Kiloton)
Table 97. South America Anti-infective API Sales by Application (2023-2028) & (Kiloton)
Table 98. Middle East & Africa Anti-infective API Sales by Region (2017-2022) & (Kiloton)
Table 99. Middle East & Africa Anti-infective API Sales by Region (2023-2028) & (Kiloton)
Table 100. Middle East & Africa Anti-infective API Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Anti-infective API Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Anti-infective API Sales by Type (2017-2022) & (Kiloton)
Table 103. Middle East & Africa Anti-infective API Sales by Type (2023-2028) & (Kiloton)
Table 104. Middle East & Africa Anti-infective API Sales by Application (2017-2022) & (Kiloton)
Table 105. Middle East & Africa Anti-infective API Sales by Application (2023-2028) & (Kiloton)
Table 106. Anti-infective API Raw Material
Table 107. Key Manufacturers of Anti-infective API Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Anti-infective API Typical Distributors
Table 111. Anti-infective API Typical Customers
List of Figures
Figure 1. Anti-infective API Picture
Figure 2. Global Anti-infective API Revenue Market Share by Type in 2021
Figure 3. β-lactam Drugs
Figure 4. Macrolides
Figure 5. Carbapenems
Figure 6. Quinolones
Figure 7. Global Anti-infective API Revenue Market Share by Application in 2021
Figure 8. Antibacterial Drugs for Systemic Use
Figure 9. Antiviral Drugs for Systemic Use
Figure 10. Antigen for Whole Body
Figure 11. Bacteria
Figure 12. Immune Serum and Immunoglobulin
Figure 13. Anti-mycobacterial Drugs
Figure 14. Vaccine
Figure 15. Other
Figure 16. Global Anti-infective API Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 17. Global Anti-infective API Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Anti-infective API Sales (2017-2028) & (Kiloton)
Figure 19. Global Anti-infective API Price (2017-2028) & (US$/Ton)
Figure 20. Global Anti-infective API Production Capacity (2017-2028) & (Kiloton)
Figure 21. Global Anti-infective API Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Anti-infective API Market Drivers
Figure 23. Anti-infective API Market Restraints
Figure 24. Anti-infective API Market Trends
Figure 25. Global Anti-infective API Sales Market Share by Manufacturer in 2021
Figure 26. Global Anti-infective API Revenue Market Share by Manufacturer in 2021
Figure 27. Anti-infective API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Anti-infective API Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Anti-infective API Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Anti-infective API Sales Market Share by Region (2017-2028)
Figure 31. Global Anti-infective API Revenue Market Share by Region (2017-2028)
Figure 32. North America Anti-infective API Revenue (2017-2028) & (USD Million)
Figure 33. Europe Anti-infective API Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Anti-infective API Revenue (2017-2028) & (USD Million)
Figure 35. South America Anti-infective API Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Anti-infective API Revenue (2017-2028) & (USD Million)
Figure 37. Global Anti-infective API Sales Market Share by Type (2017-2028)
Figure 38. Global Anti-infective API Revenue Market Share by Type (2017-2028)
Figure 39. Global Anti-infective API Price by Type (2017-2028) & (US$/Ton)
Figure 40. Global Anti-infective API Sales Market Share by Application (2017-2028)
Figure 41. Global Anti-infective API Revenue Market Share by Application (2017-2028)
Figure 42. Global Anti-infective API Price by Application (2017-2028) & (US$/Ton)
Figure 43. North America Anti-infective API Sales Market Share by Type (2017-2028)
Figure 44. North America Anti-infective API Sales Market Share by Application (2017-2028)
Figure 45. North America Anti-infective API Sales Market Share by Country (2017-2028)
Figure 46. North America Anti-infective API Revenue Market Share by Country (2017-2028)
Figure 47. United States Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Anti-infective API Sales Market Share by Type (2017-2028)
Figure 51. Europe Anti-infective API Sales Market Share by Application (2017-2028)
Figure 52. Europe Anti-infective API Sales Market Share by Country (2017-2028)
Figure 53. Europe Anti-infective API Revenue Market Share by Country (2017-2028)
Figure 54. Germany Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Anti-infective API Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Anti-infective API Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Anti-infective API Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Anti-infective API Revenue Market Share by Region (2017-2028)
Figure 63. China Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Anti-infective API Sales Market Share by Type (2017-2028)
Figure 70. South America Anti-infective API Sales Market Share by Application (2017-2028)
Figure 71. South America Anti-infective API Sales Market Share by Country (2017-2028)
Figure 72. South America Anti-infective API Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Anti-infective API Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Anti-infective API Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Anti-infective API Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Anti-infective API Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Anti-infective API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Anti-infective API in 2021
Figure 84. Manufacturing Process Analysis of Anti-infective API
Figure 85. Anti-infective API Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source